Clinical Trials List
Protocol NumberMK0822-018-21
2014-11-01 - 2019-12-15
Phase III
Terminated2
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 施翔蓉 Division of General Internal Medicine
- WEI-YIH CHIU Division of General Internal Medicine
- 詹鼎正 Division of Geriatrics
- 楊榮森 Division of Orthopedics
- 陳人豪 Division of Geriatrics
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
5000 participants
